Your browser doesn't support javascript.
loading
Phase 1 study of twice weekly pulse dose and daily low-dose erlotinib as initial treatment for patients with EGFR-mutant lung cancers.
Yu, H A; Sima, C; Feldman, D; Liu, L L; Vaitheesvaran, B; Cross, J; Rudin, C M; Kris, M G; Pao, W; Michor, F; Riely, G J.
Afiliação
  • Yu HA; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York.
  • Sima C; Weill Cornell Medical College, New York.
  • Feldman D; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York.
  • Liu LL; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York.
  • Vaitheesvaran B; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute.
  • Cross J; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA.
  • Rudin CM; Donald B. and Catherine C. Marron Cancer Metabolism Center, Sloan Kettering Institute, Sloan Kettering Cancer Center, New York.
  • Kris MG; Donald B. and Catherine C. Marron Cancer Metabolism Center, Sloan Kettering Institute, Sloan Kettering Cancer Center, New York.
  • Pao W; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York.
  • Michor F; Weill Cornell Medical College, New York.
  • Riely GJ; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York.
Ann Oncol ; 28(2): 278-284, 2017 02 01.
Article em En | MEDLINE | ID: mdl-28073786
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Receptores ErbB / Cloridrato de Erlotinib / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Receptores ErbB / Cloridrato de Erlotinib / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article